News
Pioneering a first-in-class drug-targeting approach that leverages hormone analogues to deliver small-molecule neuroplasticity modulators directly to the brain's appetite control centersFinancing ...
Pioneering a first-in-class drug-targeting approach that leverages hormone analogues to deliver small-molecule ...
The Middle East isn't just adopting digital transformation?it's engineering the future of banking with bold leadership, smart regulation, and rapid AI investment. It is in this spirit of ...
HR Path, a global leader in HR consulting and HRIS solutions, is proud to announce its strategic acquisition of smahrt ...
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and global leader in data-driven medicine, today ...
Then AstraZeneca might be the one for you! Our AstraZeneca Nordic Marketing Company employs around 550 people and has offices located in Copenhagen, Stockholm, Oslo, and Espoo. AstraZeneca Nordic is a ...
--logo-padding "" Sets the padding left and right of the logo --logo-padding-left 0 Sets the padding to the left of the logo --logo-padding-right 4 Sets the padding ...
In the last reported quarter, the company delivered a negative earnings surprise of 1.87%. AstraZeneca has an Earnings ESP of +2.73% and a Zacks Rank #3 (Hold), indicating a likely positive surprise.
Coalition partners may use the CODEPINK logo on their advertisements and promotions to highlight support for and/or joint inititatives with CODEPINK. CODEPINK is the owner of the logo and grants ...
A unit of AstraZeneca Plc is facing a new antitrust suit claiming the company monopolized the market for a blood disorder drug by blocking competitors that wanted to launch similar, less-expensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results